FIELD: chemistry.
SUBSTANCE: invention relates to the field of organic chemistry, namely to a heterocyclic compound of the formula A or its pharmaceutically acceptable salt. Also the invention relates to a pharmaceutical composition based on it and a method for treating or preventing these conditions.
.
EFFECT: new heterocyclic compound has been obtained that is useful in treating or preventing a condition associated with the substrate of the FAAH enzyme.
8 cl
| Title | Year | Author | Number |
|---|---|---|---|
| IMIDAZOLECARBOXAMIDES AND THEIR USE AS FATTY ACID AMIDE HYDROLASE INHIBITORS | 2014 |
|
RU2671404C2 |
| PYPERIDINYL NAPHTHYLUXIC ACIDS | 2012 |
|
RU2628083C2 |
| COMPOUNDS FOR TREATING CANCER | 2011 |
|
RU2609018C2 |
| NEW SUBSTITUTED QUINOLINE COMPOUNDS AS INHIBITORS OF S-NITROZOGLUTATION-REDUCTASE INHIBITORS | 2011 |
|
RU2599144C2 |
| COMPOUNDS FOR CANCER TREATMENT | 2011 |
|
RU2762111C1 |
| QUINAZOLINE DERIVATIVES | 2015 |
|
RU2704125C2 |
| {3-[(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)AZOLYL]AZETIDIN-3-YL} ACETONITRILES AS JANUS KINASE INHIBITORS | 2015 |
|
RU2601410C1 |
| CONDENSED ISOINDOLONES AS INHIBITORS OF PROTEIN KINASE C | 1996 |
|
RU2191175C2 |
| BENZOFUSED COMPOUNDS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, METHOD OF THEIR SYNTHESIS AND A METHOD OF SYNTHESIS OF AN INTERMEDIATE COMPOUND | 1992 |
|
RU2114110C1 |
| N-ACYLHYDRASONE DERIVATIVES FOR APPLICATION AS SELECTIVE INHIBITORS OF T-CELLS AND MEDICINES FOR LYMPHONEOPLASIA TREATMENT | 2013 |
|
RU2622651C2 |
